8,833
Views
43
CrossRef citations to date
0
Altmetric
Review

Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies

, &
Pages 1029-1050 | Received 20 Sep 2019, Accepted 13 Nov 2019, Published online: 27 Nov 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Tianbao Liao, Tingting Su, Lina Huang, Bixun Li & Lu-Huai Feng. (2022) Development and validation of a novel nomogram for predicting survival rate in pancreatic neuroendocrine neoplasms. Scandinavian Journal of Gastroenterology 57:1, pages 85-90.
Read now
Xiuhua Lu, Shibin Yan, Kelly Ann Koral & Zhongguang Chen. (2021) Surufatinib for the treatment of advanced extrapancreatic neuroendocrine tumors. Expert Review of Anticancer Therapy 21:9, pages 917-926.
Read now
Tetsuhide Ito & Robert T Jensen. (2021) Perspectives on the current pharmacotherapeutic strategies for management of functional neuroendocrine tumor syndromes. Expert Opinion on Pharmacotherapy 22:6, pages 685-693.
Read now

Articles from other publishers (40)

Young Mok Park, Hyung Il Seo, Byeong Gwan Noh, Suk Kim, Seung Baek Hong, Nam Kyung Lee, Dong Uk Kim & Sung Yong Han. (2023) Clinicopathological characteristics of extrahepatic biliary neuroendocrine neoplasms in the gallbladder, extrahepatic biliary tract, and ampulla of Vater: A single-center cross-sectional study. Annals of Hepato-Biliary-Pancreatic Surgery 27:4, pages 380-387.
Crossref
Yong-Jin Park, Young Suk Park, Seung Tae Kim & Seung Hyup Hyun. (2023) A Machine Learning Approach Using [18F]FDG PET-Based Radiomics for Prediction of Tumor Grade and Prognosis in Pancreatic Neuroendocrine Tumor. Molecular Imaging and Biology 25:5, pages 897-910.
Crossref
Jiao Ma, Xiaoyong Wang, Mingsong Tang & Chunyin Zhang. (2023) Preoperative prediction of pancreatic neuroendocrine tumor grade based on 68Ga-DOTATATE PET/CT. Endocrine.
Crossref
Ludovica Magi, Matteo Marasco, Maria Rinzivillo, Antongiulio Faggiano & Francesco Panzuto. (2023) Management of Functional Pancreatic Neuroendocrine Neoplasms. Current Treatment Options in Oncology 24:7, pages 725-741.
Crossref
Isa Mulingbayan Jacoba & H. Christian Weber. (2023) Biomarkers in gastroenteropancreatic neuroendocrine neoplasms. Current Opinion in Endocrinology, Diabetes & Obesity 30:3, pages 175-180.
Crossref
Yu-Fan Meng, Zhi-Yao Fan, Jian Yang, Yong-Zheng Li, Shu-Jie Liu, Chang-Hao Gao, Xin Gao, Chao-Yu Pang & Han-Xiang Zhan. (2023) The characteristics of serum lipid spectrum in PanNENs and its correlation with clinicopathological features and prognosis. Frontiers in Endocrinology 14.
Crossref
Margarita Ptasnuka, Arturs Truskovs, Arturs Ozolins, Zenons Narbuts, Maris Sperga & Haralds Plaudis. (2023) Sporadic pancreatic neuroendocrine neoplasms: A retrospective clinicopathological and outcome analysis from a Latvian study group. Frontiers in Surgery 10.
Crossref
Sami Matrood, Leander Edwin Melms, Detlef Klaus Bartsch & Pietro Di Fazio. (2023) The Expression of Autophagy-Associated Genes Represents a Valid Footprint for Aggressive Pancreatic Neuroendocrine Neoplasms. International Journal of Molecular Sciences 24:4, pages 3636.
Crossref
Satoshi Komiyama, Takuji Okusaka, Yuta Maruki, Akihiro Ohba, Yoshikuni Nagashio, Shunsuke Kondo, Susumu Hijioka, Chigusa Morizane, Hideki Ueno, Aoi Sukeda, Takahiro Mizui, Takeshi Takamoto, Satoshi Nara, Daisuke Ban, Minoru Esaki, Nobuyoshi Hiraoka & Kazuaki Shimada. (2023) Clinicopathological Findings and Treatment Outcomes of Patients with Primary Hepatobiliary Neuroendocrine Neoplasms: A Retrospective Single-institution Analysis. Internal Medicine.
Crossref
Baltasar Pérez-Saborido, Martín Bailón-Cuadrado, Francisco Javier Tejero-Pintor, Ekta Choolani-Bhojwani, Pablo Marcos-Santos & David Pacheco-Sánchez. 2023. Recent Innovations in Surgical Procedures of Pancreatic Neoplasms. Recent Innovations in Surgical Procedures of Pancreatic Neoplasms 35 53 .
X. Liu, B. Chen, J. Chen, Z. Su & S. Sun. (2022) The incidence, prevalence, and survival analysis of pancreatic neuroendocrine tumors in the United States. Journal of Endocrinological Investigation 46:7, pages 1373-1384.
Crossref
Li Quan, Yongkang Liu, Wenjing Cui, Xinru Wang, Weixiao Zhang, Zhongqiu Wang, Chuangen Guo, Chao Lu, Feixiang Hu & Xiao Chen. (2022) The associations between serum high-density lipoprotein cholesterol levels and malignant behavior in pancreatic neuroendocrine neoplasms. Lipids in Health and Disease 21:1.
Crossref
Bor-Shiuan Shyr, Bor-Uei Shyr, Shih-Chin Chen, Yi-Ming Shyr & Shin-E Wang. (2022) Impact of tumor grade on pancreatic neuroendocrine tumors. Asian Journal of Surgery 45:12, pages 2659-2663.
Crossref
M. V. Lysanyuk, P. N. Romashchenko & N. A. Maistrenko. (2022) Modern opportunities and problematic aspects of diagnostics and treatment of patients with neuroendocrine tumors. Perm Medical Journal 39:5, pages 58-68.
Crossref
Mengfei Fu, Li Yu, Liu Yang, Yang Chen, Xiao Chen, Qinyu Hu & Hui Sun. (2022) Predictive value of the preoperative prognostic nutritional index for postoperative progression in patients with pancreatic neuroendocrine neoplasms. Frontiers in Nutrition 9.
Crossref
Wenzel M. Hackeng, Hussein A. Assi, Florine H.M. Westerbeke, Lodewijk A.A. Brosens & Christopher M. Heaphy. (2022) Prognostic and Predictive Biomarkers for Pancreatic Neuroendocrine Tumors. Surgical Pathology Clinics 15:3, pages 541-554.
Crossref
R. M. Ruggeri, E. Benevento, F. De Cicco, B. Fazzalari, E. Guadagno, I. Hasballa, M. G. Tarsitano, A. M. Isidori, A. Colao, A. Faggiano, I Aini, M Albertelli, Y Alessi, B Altieri, S Antonini, L Barrea, F Birtolo, F Campolo, G Cannavale, C Cantone, S Carra, R Centello, A Cozzolino, S Molfetta, V Vito, G Fanciulli, T Feola, F Ferraù, S Gay, E Giannetta, F Grillo, E Grossrubatscher, V Guarnotta, A Salvia, A Laffi, A Lania, A Liccardi, P Malandrino, R Mazzilli, E Messina, N Mikovic, R Minotta, R Modica, G Muscogiuri, C Pandozzi, G Pugliese, G Puliani, A Ragni, M Rubino, F Russo, F Sesti, L Verde, A Veresani, C Vetrani, G Vitale, V Zamponi & I Zanata. (2022) Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies. Journal of Endocrinological Investigation 46:2, pages 213-234.
Crossref
Roberta Angelico, Leandro Siragusa, Cristine Brooke Pathirannehalage Don, Bruno Sensi, Federica Billeci, Leonardo Vattermoli, Belen Padial, Giampiero Palmieri, Alessandro Anselmo, Alessandro Coppola, Giuseppe Tisone & Tommaso Maria Manzia. (2022) Pancreatic Adeno-MiNEN, a Rare Newly Defined Entity with Challenging Diagnosis and Treatment: A Case Report with Systematic Literature Review and Pooled Analysis. Journal of Clinical Medicine 11:17, pages 5021.
Crossref
Jacques A. Greenberg, Nikolay A Ivanov, Caitlin E. Egan, Yeon Joo Lee, Rasa Zarnegar, Thomas J. FaheyIIIIII, Brendan M. Finnerty & Irene M. Min. (2022) Sex-Based Clinicopathologic and Survival Differences Among Patients with Pancreatic Neuroendocrine Tumors. Journal of Gastrointestinal Surgery.
Crossref
Shu‐tao Ma, Ding‐yuan Wang, Yi‐bing Liu, Hui‐jing Tan, Yue‐yue Ge, Yihebali Chi & Bai‐lin Zhang. (2022) Prognostic factors of primary neuroendocrine breast cancer: A population‐based study. Cancer Medicine 11:13, pages 2533-2540.
Crossref
Jingzhi Huang, Xiaohua Xie, Hong Wu, Xiaoer Zhang, Yanling Zheng, Xiaoyan Xie, Yi Wang & Ming Xu. (2022) Development and validation of a combined nomogram model based on deep learning contrast-enhanced ultrasound and clinical factors to predict preoperative aggressiveness in pancreatic neuroendocrine neoplasms. European Radiology 32:11, pages 7965-7975.
Crossref
Yun Bian, Hui Jiang, Jianming Zheng, Chengwei Shao & Jianping Lu. (2022) Basic pancreatic lesions: Radiologic-pathologic correlation. Journal of Translational Internal Medicine 10:1, pages 18-27.
Crossref
Rui Zheng-PywellAlexandra Lopez-AguiarRyan C FieldsSelwyn VickersClayton YatesVikas DudejaHerbert ChenSushanth ReddyShishir K MaithelJ Bart Rose. (2022) Are We Undertreating Black Patients with Nonfunctional Pancreatic Neuroendocrine Tumors? Critical Analysis of Current Surveillance Guidelines by Race. Journal of the American College of Surgeons 234:4, pages 599-606.
Crossref
Jiale Hou, Tingting Long, Yi Yang, Dengming Chen & Shuo Hu. (2022) The Potential Prognostic Value of Dual-Imaging PET Parameters Based on 18F-FDG and 18F-OC for Neuroendocrine Neoplasms. Molecular Imaging 2022, pages 1-9.
Crossref
Alexander R. Siebenhüner, Melanie Langheinrich, Juliane Friemel, Niklaus Schäfer, Dilmurodjon Eshmuminov & Kuno Lehmann. (2022) Orchestrating Treatment Modalities in Metastatic Pancreatic Neuroendocrine Tumors—Need for a Conductor. Cancers 14:6, pages 1478.
Crossref
Lingaku Lee, Irene Ramos-Alvarez & Robert T. Jensen. (2022) Predictive Factors for Resistant Disease with Medical/Radiologic/Liver-Directed Anti-Tumor Treatments in Patients with Advanced Pancreatic Neuroendocrine Neoplasms: Recent Advances and Controversies. Cancers 14:5, pages 1250.
Crossref
Fei Wang, Jihyun Ma, Nan Zhao, Chi Lin & Haixing Jiang. (2022) Racial Disparities in Clinical Features and Survival Outcomes among Patients with Pancreatic Neuroendocrine Tumor: A Contemporary SEER Database Analysis. Oncologie 24:4, pages 865-895.
Crossref
Jingxuan Wang, Jianhua Liu, Chao He, Tiantian Sun, Yan Yan, Gang Che, Xuemin Li, Huanhuan Sun & Haiqing Ma. (2021) Trends in Incidence and Survival of Patients with Pancreatic Neuroendocrine Neoplasm, 1987–2016. Journal of Oncology 2021, pages 1-11.
Crossref
Junzhang Chen, Yongyu Yang, Yuanhua Liu & Heping Kan. (2021) Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation. World Journal of Surgical Oncology 19:1.
Crossref
Anil Aysal, Cihan Agalar, Tufan Egeli, Tarkan Unek, Ilhan Oztop, Funda Obuz & Ozgul Sagol. (2021) Reconsideration of Clinicopathologic Prognostic Factors in Pancreatic Neuroendocrine Tumors for Better Determination of Adverse Prognosis. Endocrine Pathology 32:4, pages 461-472.
Crossref
Jiale Hou, Yi Yang, Na Chen, Dengming Chen & Shuo Hu. (2021) Prognostic Value of Volume-Based Parameters Measured by SSTR PET/CT in Neuroendocrine Tumors: A Systematic Review and Meta-Analysis. Frontiers in Medicine 8.
Crossref
Moises Cukier, Ruth Vergara, Jorge Mendez‑Rios, Omar Castillo, Irma Barrera, Eliecer Tello, Olivia El Achtar, Yong Loo, Hector Tapia, Guadalupe Perez & Maximino Peña. (2021) Neuroendocrine tumors in Panama: A nationwide database analysis. Molecular and Clinical Oncology 15:2.
Crossref
Przemysław Soczomski, Beata Jurecka-Lubieniecka, Aleksandra Krzywon, Alexander Jorge Cortez, Stanisław Zgliczynski, Natalia Rogozik, Małgorzata Oczko-Wojciechowska, Agnieszka Pawlaczek, Tomasz Bednarczuk & Barbara Jarzab. (2021) A Direct Comparison of Patients With Hereditary and Sporadic Pancreatic Neuroendocrine Tumors: Evaluation of Clinical Course, Prognostic Factors and Genotype–Phenotype Correlations. Frontiers in Endocrinology 12.
Crossref
Maria Luisa Brandi, Sunita K Agarwal, Nancy D Perrier, Kate E Lines, Gerlof D Valk & Rajesh V Thakker. (2021) Multiple Endocrine Neoplasia Type 1: Latest Insights. Endocrine Reviews 42:2, pages 133-170.
Crossref
Si Xie, Lei Li, Xiaotong Wang & Lequn Li. (2021) Development and validation of a nomogram for predicting the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms. Medicine 100:2, pages e24223.
Crossref
Antonio Viúdez, Guillermo Crespo, María Luisa Gómez Dorronsoro, Imanol Arozarena, Juan Jesús Marín-Méndez, Ana Custodio, Marta Benavent, Saioa Goñi, Beatriz García-Paredes, Jorge Hernando, Maika Durantez, Vicente Alonso, María del Carmen Riesco, Carlos López, Paula Jiménez-Fonseca, Borja López San Vicente, Iranzu González-Borja, Isabel Sevilla, Irene Hernández-Garcia, Alberto Carmona-Bayonas, Jaume Capdevila, Jairo Pérez-Sanz, Rocío García-Carbonero, Leyre Pérez-Ricarte, Marta Llanos, Ruth Vera & Ana De Jesús Acosta. (2021) Usefulness of an immunohistochemical score in advanced pancreatic neuroendocrine tumors treated with CAPTEM or everolimus. Pancreatology 21:1, pages 215-223.
Crossref
Brigida Anna Maiorano, Giovanni Schinzari, Sabrina Chiloiro, Felicia Visconti, Domenico Milardi & Antonio Bianchi. (2020) Proteomics of Pancreatic Neuroendocrine Tumors: A Systematic Review. Protein & Peptide Letters 27:12, pages 1276-1287.
Crossref
Rui He, Wunai Zhang, Shuo Chen, Yang Liu, Wenbin Yang & Junhui Li. (2020) Transcriptional Profiling Reveals the Regulatory Role of DNER in Promoting Pancreatic Neuroendocrine Neoplasms. Frontiers in Genetics 11.
Crossref
Juwan Kim, Ho Kyoung Hwang, Woo Jung Lee & Chang Moo Kang. (2020) Minimally invasive vs open pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors . World Journal of Gastrointestinal Oncology 12:10, pages 1133-1145.
Crossref
Bang-Bin Chen. (2020) Artificial intelligence in pancreatic disease. Artificial Intelligence in Medical Imaging 1:1, pages 19-30.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.